Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login
How Metformin Impacts Cancer Metabolism: A Simple Overview

How Metformin Impacts Cancer Metabolism: A Simple Overview

Share Post:

Metformin, a common diabetes medication, has shown significant potential in fighting cancer. Its impact on how cells produce energy, particularly in mitochondria, has been effective against various cancers, including breast, prostate, pancreatic, lung, and liver cancers. This article will explain how Metformin affects cancer cells and its potential as an anti-cancer treatment.

How Metformin Causes Stress in Cancer Cells

Metformin creates a type of stress in cells known as metabolic stress. Healthy cells can handle this stress and may even become stronger, but cancer cells, which are already weak, struggle to survive. This stress is a key reason Metformin could prevent cancer from developing if used early.

How Metformin Works Against Cancer

Here’s a breakdown of how Metformin fights cancer:

  1. Entering Cells: Metformin gets into cells through a transporter called OCT1.
  2. Mitochondrial Effect: Once inside, at high concentrations, Metformin binds to a part of the mitochondria called complex 1, slowing down its function. This reduces the cell’s ability to produce energy (ATP), triggering a chain reaction that activates AMPK, a protein that stops another protein called mTOR, which is needed for cancer cells to grow.
  3. Blocking Fat Production: Metformin also stops acetyl-CoA from entering the TCA cycle, a process that produces fats necessary for cancer cell growth. By blocking this, Metformin helps stop cancer from spreading.
  4. Promoting Cell Death: Metformin increases the ratio of BAX (a protein that promotes cell death) to BCL2 (a protein that prevents cell death). This makes it more likely that cancer cells will die. The increase in BAX triggers a series of events that lead to the death of cancer cells.

Balancing Energy Production

Metformin doesn’t completely shut down energy production in cells because that would be harmful to all cells, not just cancerous ones. Instead, it carefully reduces the energy production in a way that is deadly to cancer cells but tolerable for healthy cells. This selective targeting is what makes Metformin an effective potential treatment for cancer.

Metformin’s Promise in Cancer Treatment

Metformin’s ability to create stress that cancer cells can’t survive, while sparing healthy cells, shows its potential as a powerful anti-cancer agent. By targeting crucial pathways that cancer cells rely on, Metformin could become a key tool in cancer treatment and prevention. Understanding these effects helps us optimize how we use Metformin in fighting cancer, offering hope for better therapies in the future. 

Medically Reviewed

Profile image of Dr Pawel Zawadzki

Medically Reviewed By Dr Pawel ZawadzkiDr. Pawel Zawadzki, a U.S.-licensed MD from McMaster University and Poznan Medical School, specializes in family medicine, advocates for healthy living, and enjoys outdoor activities, reflecting his holistic approach to health.

Profile image of CDI Staff Writer

Written by CDI Staff Writer on September 17, 2024

Related Products

There are no related matching items at this time. Please check again soon.

Related Articles

Cancer
Metformin in Prediabetes: Role in Prevention and Impact on Vitamin B12 Absorption

Understanding PrediabetesPrediabetes is a metabolic condition where blood sugar levels are higher than normal but not high enough to be classified as type 2 diabetes. It is diagnosed using criteria…

Read More
Cancer
Colorectal Cancer (CRC) and Metformin: A Promising Combination for Prevention and Treatment in Diabetic Individuals

Colorectal cancer (CRC) is the third most common malignancy worldwide for both men and women. According to the World Health Organization (WHO), approximately 1.9 million new cases were diagnosed in…

Read More
Cancer
Osteosarcoma: Metformin’s Potential Future Role in Treatment

Osteosarcoma is the most common type of primary bone cancer, affecting adolescents and young adults at an incidence rate of 3-4 cases per million people annually. This aggressive malignancy usually…

Read More
Cancer
Can Metformin Revolutionize the Treatment of Acute Lymphoblastic Leukemia (ALL)?

Acute lymphoblastic leukemia (ALL) is a cancer affecting lymphocytes, primarily impacting children but also prevalent in adults over 50. With an incidence rate of 1-4 per 100,000 globally, ALL is…

Read More